ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

W-Q Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5044925368. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper

Papers 2

Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/bjs.10187 ↗
Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic cancer. Co-author DOI 10.1038/onc.2013.223 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

C. Liu · 2 shared papers, 2014–2016 · strength 0.09
- Paper Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma. DOI 10.1002/bjs.10187 ↗
- Paper Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic can… DOI 10.1038/onc.2013.223 ↗
Xianjun Yu · 2 shared papers, 2014–2016 · strength 0.09
- Paper Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma. DOI 10.1002/bjs.10187 ↗
- Paper Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic can… DOI 10.1038/onc.2013.223 ↗
B. Zhang · 1 shared paper, 2014 · strength 0.04
- Paper Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic can… DOI 10.1038/onc.2013.223 ↗
Lei Liu · 1 shared paper, 2014 · strength 0.04
- Paper Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic can… DOI 10.1038/onc.2013.223 ↗
Yi Qin · 1 shared paper, 2014 · strength 0.04
- Paper Cavin-1 is essential for the tumor-promoting effect of caveolin-1 and enhances its prognostic potency in pancreatic can… DOI 10.1038/onc.2013.223 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.